Items Tagged ‘Dean Wingerchuk’

March 29, 2010

Test Predicts Which Patients Benefit From $6 Billion MS Drugs

By Mystery User

Multiple sclerosis drugs from Biogen Idec Inc., Merck KGaA and Bayer AG with sales of $6.1 billion work for fewer than 3 in 4 patients and a test can predict which ones, a study found…   “This information could allow us to better select a group of people who are likely to respond in the […]

View full entry

Tags: Dean Wingerchuk, multiple sclerosis

Contact Us · Privacy Policy